RANI Rani Therapeutics Holdings, Inc. Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
11:49
May 16
Long $RANI (Rani Therapeutics) — clinical-stage pharma/medtech developing oral form for peptides/proteins, partnership with Chugai, cash runway until Q4 2027, MC $200M; potential buyout target. Speaker took a tiny speculative position.
RANI 1ST
MED

About RANI Analyst Coverage

Buzzberg tracks RANI (Rani Therapeutics Holdings, Inc.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Latest voices: frenchv33921.